Literature DB >> 6770848

Pathways in the activation of human coagulation factor X.

K Mertens, R M Bertina.   

Abstract

Purified human Factor X (apparent mol.wt. 72000), which consists of two polypeptide chains (mol.wt. 55000 and 19000), was activated by both Russell's-viper venom and the purified physiological activators (Factor VII/tissue factor and Factor IXa/Factor VIII). They all convert Factor X to catalytically active Factor Xa (mol.wt. 54000) by cleaving the heavy chain at a site on the N-terminal region. In the presence of Ca2+ and phospholipid, the Factor Xa formed catalyses (a) the cleavage of a small peptide (mol.wt. 4000) from the C-terminal region of the heavy chain of Factor Xa, resulting in a second active form (mol.wt. 50000), and (b) the cleavage of a peptide containing the active-site serine residue (mol.wt. 13000) from the C-terminal region of the heavy chain of Factor X, resulting in an inactivatable component (mol.wt. 59000). A nomenclature for the various products is proposed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6770848      PMCID: PMC1161442          DOI: 10.1042/bj1850647

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Human erythrocyte membrane glycoprotein: a re-evaluation of the molecular weight as determined by SDS polyacrylamide gel electrophoresis.

Authors:  J P Segrest; R L Jackson; E P Andrews; V T Marchesi
Journal:  Biochem Biophys Res Commun       Date:  1971-07-16       Impact factor: 3.575

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  The mechanism of activation of factor X. Kinetic control of alternative pathways leading to the formation of activated factor X.

Authors:  J Jesty; A K Spencer; Y Nemerson
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

4.  Bovine factor X 1a (activated Stuart factor). Evidence of homology with mammalian serine proteases.

Authors:  K Titani; M A Hermodson; K Fujikawa; L H Ericsson; K A Walsh; H Neurath; E W Davie
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

5.  Purification of Factor VII from bovine plasma. Reaction with tissue factor and activation of Factor X.

Authors:  J Jesty; Y Nemerson
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

6.  Bovine factor X 1 (Stuart factor). Mechanism of activation by protein from Russell's viper venom.

Authors:  K Fujikawa; M E Legaz; E W Davie
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

7.  Artificial reagents for factor VII and factor X, a computer programme for obtaining reference tables for one-stage determinations in the extrinsic system.

Authors:  H C Hemker; A C Swart; A J Alink
Journal:  Thromb Diath Haemorrh       Date:  1972-04-30

8.  Detection of the carrier state in hereditary coagulation disorders. I.

Authors:  J J Veltkamp; E F Drion; E A Loeliger
Journal:  Thromb Diath Haemorrh       Date:  1968-03-31

9.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

10.  The preparation of activated factor X and its action on prothrombin.

Authors:  J Jesty; M P Esnouf
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

View more
  14 in total

1.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

2.  Mass spectrometry-assisted study reveals that lysine residues 1967 and 1968 have opposite contribution to stability of activated factor VIII.

Authors:  Esther Bloem; Henriet Meems; Maartje van den Biggelaar; Carmen van der Zwaan; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

3.  Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.

Authors:  J Franssen; I Salemink; G M Willems; T C Wun; H C Hemker; T Lindhout
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

4.  Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma.

Authors:  Atanur Ersayin; Aline Thomas; Landry Seyve; Nicole Thielens; Mathieu Castellan; Raphaël Marlu; Benoît Polack; Marie-Claire Dagher
Journal:  Haematologica       Date:  2017-10-05       Impact factor: 9.941

5.  Factor VIII C1 domain spikes 2092-2093 and 2158-2159 comprise regions that modulate cofactor function and cellular uptake.

Authors:  Esther Bloem; Maartje van den Biggelaar; Aleksandra Wroblewska; Jan Voorberg; Johan H Faber; Marianne Kjalke; Henning R Stennicke; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2013-09-05       Impact factor: 5.157

6.  Losac, the first hemolin that exhibits procogulant activity through selective factor X proteolytic activation.

Authors:  Miryam Paola Alvarez-Flores; Daniel Furlin; Oscar H P Ramos; Andrea Balan; Katsuhiro Konno; Ana Marisa Chudzinski-Tavassi
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

7.  Structure and dynamics of zymogen human blood coagulation factor X.

Authors:  Divi Venkateswarlu; Lalith Perera; Tom Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

8.  Binding of human blood-coagulation Factors IXa and X to phospholipid membranes.

Authors:  K Mertens; R Cupers; A Van Wijngaarden; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

9.  The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

10.  A factor X-activating cysteine protease from malignant tissue.

Authors:  S G Gordon; B A Cross
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.